Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue 1.4 Market Analysis by Type 1.4.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Hormones and Antagonists 1.4.3 Microorganism Products 1.4.4 Plant Products 1.4.5 Antitumor Antibiotics 1.4.6 Alkylating Agents 1.4.7 Antimetabolites 1.4.8 Natural Products 1.5 Market by Application 1.5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2026 1.5.2 Lung Cancer 1.5.3 Bladder Cancer 1.5.4 Breast Cancer 1.5.5 Cervical Cancer 1.5.6 Leukemia 1.5.7 Gynecological Cancer 1.5.8 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Anti-Neoplastic Pharmaceutical Agents Market Perspective (2015-2026) 2.2 Anti-Neoplastic Pharmaceutical Agents Growth Trends by Regions 2.2.1 Anti-Neoplastic Pharmaceutical Agents Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Anti-Neoplastic Pharmaceutical Agents Historic Market Share by Regions (2015-2020) 2.2.3 Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Anti-Neoplastic Pharmaceutical Agents Market Growth Strategy 2.3.6 Primary Interviews with Key Anti-Neoplastic Pharmaceutical Agents Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Market Size 3.1.1 Global Top Anti-Neoplastic Pharmaceutical Agents Players by Revenue (2015-2020) 3.1.2 Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Players (2015-2020) 3.1.3 Global Anti-Neoplastic Pharmaceutical Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio 3.2.1 Global Anti-Neoplastic Pharmaceutical Agents Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Anti-Neoplastic Pharmaceutical Agents Revenue in 2019 3.3 Anti-Neoplastic Pharmaceutical Agents Key Players Head office and Area Served 3.4 Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service 3.5 Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Anti-Neoplastic Pharmaceutical Agents Historic Market Size by Type (2015-2020) 4.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Type (2021-2026) 5 Anti-Neoplastic Pharmaceutical Agents Breakdown Data by Application (2015-2026) 5.1 Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) 5.2 Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020) 6.2 Anti-Neoplastic Pharmaceutical Agents Key Players in North America (2019-2020) 6.3 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) 6.4 North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) 7 Europe 7.1 Europe Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020) 7.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Europe (2019-2020) 7.3 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) 7.4 Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) 8 China 8.1 China Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020) 8.2 Anti-Neoplastic Pharmaceutical Agents Key Players in China (2019-2020) 8.3 China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) 8.4 China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) 9 Japan 9.1 Japan Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020) 9.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Japan (2019-2020) 9.3 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) 9.4 Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020) 10.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) 10.4 Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) 11 India 11.1 India Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020) 11.2 Anti-Neoplastic Pharmaceutical Agents Key Players in India (2019-2020) 11.3 India Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) 11.4 India Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size (2015-2020) 12.2 Anti-Neoplastic Pharmaceutical Agents Key Players in Central & South America (2019-2020) 12.3 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) 12.4 Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) 13Key Players Profiles 13.1 GlaxoSmithKline plc. 13.1.1 GlaxoSmithKline plc. Company Details 13.1.2 GlaxoSmithKline plc. Business Overview and Its Total Revenue 13.1.3 GlaxoSmithKline plc. Anti-Neoplastic Pharmaceutical Agents Introduction 13.1.4 GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020)) 13.1.5 GlaxoSmithKline plc. Recent Development 13.2 F. Hoffmann-La Roche Ltd 13.2.1 F. Hoffmann-La Roche Ltd Company Details 13.2.2 F. Hoffmann-La Roche Ltd Business Overview and Its Total Revenue 13.2.3 F. Hoffmann-La Roche Ltd Anti-Neoplastic Pharmaceutical Agents Introduction 13.2.4 F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) 13.2.5 F. Hoffmann-La Roche Ltd Recent Development 13.3 Eli Lilly and Company 13.3.1 Eli Lilly and Company Company Details 13.3.2 Eli Lilly and Company Business Overview and Its Total Revenue 13.3.3 Eli Lilly and Company Anti-Neoplastic Pharmaceutical Agents Introduction 13.3.4 Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) 13.3.5 Eli Lilly and Company Recent Development 13.4 Bristol-Myers Squibb Company 13.4.1 Bristol-Myers Squibb Company Company Details 13.4.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue 13.4.3 Bristol-Myers Squibb Company Anti-Neoplastic Pharmaceutical Agents Introduction 13.4.4 Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) 13.4.5 Bristol-Myers Squibb Company Recent Development 13.5 Becton, Dickinson and Company 13.5.1 Becton, Dickinson and Company Company Details 13.5.2 Becton, Dickinson and Company Business Overview and Its Total Revenue 13.5.3 Becton, Dickinson and Company Anti-Neoplastic Pharmaceutical Agents Introduction 13.5.4 Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) 13.5.5 Becton, Dickinson and Company Recent Development 13.6 Pfizer Inc. 13.6.1 Pfizer Inc. Company Details 13.6.2 Pfizer Inc. Business Overview and Its Total Revenue 13.6.3 Pfizer Inc. Anti-Neoplastic Pharmaceutical Agents Introduction 13.6.4 Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) 13.6.5 Pfizer Inc. Recent Development 13.7 Novartis AG 13.7.1 Novartis AG Company Details 13.7.2 Novartis AG Business Overview and Its Total Revenue 13.7.3 Novartis AG Anti-Neoplastic Pharmaceutical Agents Introduction 13.7.4 Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) 13.7.5 Novartis AG Recent Development 13.8 AstraZeneca 13.8.1 AstraZeneca Company Details 13.8.2 AstraZeneca Business Overview and Its Total Revenue 13.8.3 AstraZeneca Anti-Neoplastic Pharmaceutical Agents Introduction 13.8.4 AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) 13.8.5 AstraZeneca Recent Development 13.9 Gilead 13.9.1 Gilead Company Details 13.9.2 Gilead Business Overview and Its Total Revenue 13.9.3 Gilead Anti-Neoplastic Pharmaceutical Agents Introduction 13.9.4 Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) 13.9.5 Gilead Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Anti-Neoplastic Pharmaceutical Agents Key Market Segments Table 2. Key Players Covered: Ranking by Anti-Neoplastic Pharmaceutical Agents Revenue Table 3. Ranking of Global Top Anti-Neoplastic Pharmaceutical Agents Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Hormones and Antagonists Table 6. Key Players of Microorganism Products Table 7. Key Players of Plant Products Table 8. Key Players of Antitumor Antibiotics Table 9. Key Players of Alkylating Agents Table 10. Key Players of Antimetabolites Table 11. Key Players of Natural Products Table 12. Global Anti-Neoplastic Pharmaceutical Agents Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2015-2020) Table 16. Global Anti-Neoplastic Pharmaceutical Agents Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Anti-Neoplastic Pharmaceutical Agents Market Growth Strategy Table 22. Main Points Interviewed from Key Anti-Neoplastic Pharmaceutical Agents Players Table 23. Global Anti-Neoplastic Pharmaceutical Agents Revenue by Players (2015-2020) (Million US$) Table 24. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players (2015-2020) Table 25. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019) Table 26. Global Anti-Neoplastic Pharmaceutical Agents by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Anti-Neoplastic Pharmaceutical Agents Product Solution and Service Table 29. Date of Enter into Anti-Neoplastic Pharmaceutical Agents Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$) Table 32. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Type (2015-2020) Table 33. Global Anti-Neoplastic Pharmaceutical Agents Revenue Market Share by Type (2021-2026) Table 34. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2015-2020) Table 35. Global Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$) Table 36. Global Anti-Neoplastic Pharmaceutical Agents Market Size Share by Application (2021-2026) Table 37. North America Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$) Table 38. North America Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020) Table 39. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$) Table 40. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020) Table 41. North America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$) Table 42. North America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020) Table 43. Europe Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020) Table 45. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$) Table 46. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020) Table 47. Europe Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$) Table 48. Europe Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020) Table 49. China Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$) Table 50. China Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020) Table 51. China Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$) Table 52. China Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020) Table 53. China Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$) Table 54. China Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020) Table 55. Japan Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020) Table 57. Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$) Table 58. Japan Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020) Table 59. Japan Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$) Table 60. Japan Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020) Table 63. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020) Table 65. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020) Table 67. India Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$) Table 68. India Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020) Table 69. India Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$) Table 70. India Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020) Table 71. India Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$) Table 72. India Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020) Table 73. Central & South America Key Players Anti-Neoplastic Pharmaceutical Agents Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Anti-Neoplastic Pharmaceutical Agents Market Share (2019-2020) Table 75. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Share by Type (2015-2020) Table 77. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Share by Application (2015-2020) Table 79. GlaxoSmithKline plc. Company Details Table 80. GlaxoSmithKline plc. Business Overview Table 81. GlaxoSmithKline plc. Product Table 82. GlaxoSmithKline plc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$) Table 83. GlaxoSmithKline plc. Recent Development Table 84. F. Hoffmann-La Roche Ltd Company Details Table 85. F. Hoffmann-La Roche Ltd Business Overview Table 86. F. Hoffmann-La Roche Ltd Product Table 87. F. Hoffmann-La Roche Ltd Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$) Table 88. F. Hoffmann-La Roche Ltd Recent Development Table 89. Eli Lilly and Company Company Details Table 90. Eli Lilly and Company Business Overview Table 91. Eli Lilly and Company Product Table 92. Eli Lilly and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$) Table 93. Eli Lilly and Company Recent Development Table 94. Bristol-Myers Squibb Company Company Details Table 95. Bristol-Myers Squibb Company Business Overview Table 96. Bristol-Myers Squibb Company Product Table 97. Bristol-Myers Squibb Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$) Table 98. Bristol-Myers Squibb Company Recent Development Table 99. Becton, Dickinson and Company Company Details Table 100. Becton, Dickinson and Company Business Overview Table 101. Becton, Dickinson and Company Product Table 102. Becton, Dickinson and Company Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$) Table 103. Becton, Dickinson and Company Recent Development Table 104. Pfizer Inc. Company Details Table 105. Pfizer Inc. Business Overview Table 106. Pfizer Inc. Product Table 107. Pfizer Inc. Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$) Table 108. Pfizer Inc. Recent Development Table 109. Novartis AG Company Details Table 110. Novartis AG Business Overview Table 111. Novartis AG Product Table 112. Novartis AG Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$) Table 113. Novartis AG Recent Development Table 114. AstraZeneca Business Overview Table 115. AstraZeneca Product Table 116. AstraZeneca Company Details Table 117. AstraZeneca Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$) Table 118. AstraZeneca Recent Development Table 119. Gilead Company Details Table 120. Gilead Business Overview Table 121. Gilead Product Table 122. Gilead Revenue in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) (Million US$) Table 123. Gilead Recent Development Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Type: 2020 VS 2026 Figure 2. Hormones and Antagonists Features Figure 3. Microorganism Products Features Figure 4. Plant Products Features Figure 5. Antitumor Antibiotics Features Figure 6. Alkylating Agents Features Figure 7. Antimetabolites Features Figure 8. Natural Products Features Figure 9. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Application: 2020 VS 2026 Figure 10. Lung Cancer Case Studies Figure 11. Bladder Cancer Case Studies Figure 12. Breast Cancer Case Studies Figure 13. Cervical Cancer Case Studies Figure 14. Leukemia Case Studies Figure 15. Gynecological Cancer Case Studies Figure 16. Other Case Studies Figure 17. Anti-Neoplastic Pharmaceutical Agents Report Years Considered Figure 18. Global Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth 2015-2026 (US$ Million) Figure 19. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions: 2020 VS 2026 Figure 20. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Regions (2021-2026) Figure 21. Porter's Five Forces Analysis Figure 22. Global Anti-Neoplastic Pharmaceutical Agents Market Share by Players in 2019 Figure 23. Global Top Anti-Neoplastic Pharmaceutical Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Neoplastic Pharmaceutical Agents as of 2019 Figure 24. The Top 10 and 5 Players Market Share by Anti-Neoplastic Pharmaceutical Agents Revenue in 2019 Figure 25. North America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Europe Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$) Figure 27. China Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Japan Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$) Figure 29. Southeast Asia Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$) Figure 30. India Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$) Figure 31. Central & South America Anti-Neoplastic Pharmaceutical Agents Market Size YoY Growth (2015-2020) (Million US$) Figure 32. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. GlaxoSmithKline plc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) Figure 34. F. Hoffmann-La Roche Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) Figure 36. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Eli Lilly and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) Figure 38. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Bristol-Myers Squibb Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) Figure 40. Becton, Dickinson and Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Becton, Dickinson and Company Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) Figure 42. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Pfizer Inc. Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) Figure 44. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Novartis AG Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) Figure 46. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. AstraZeneca Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) Figure 48. Gilead Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Gilead Revenue Growth Rate in Anti-Neoplastic Pharmaceutical Agents Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

GlaxoSmithKline plc. F. Hoffmann-La Roche Ltd Eli Lilly and Company Bristol-Myers Squibb Company Becton, Dickinson and Company Pfizer Inc. Novartis AG AstraZeneca Gilead